Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Search help
260 results
  1. Breast Cancer Treatment (Adult) (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK65744
    ... agents for the treatment of TNBC. Poly (ADP-ribose) polymerase (PARP) inhibitor agents The PARP inhibitors are ... Winer EP, Ford JM, et al.: Poly(ADP-Ribose) polymerase inhibition: "targeted" therapy for triple-negative breast ...
  2. MedlinePlus Drug Information: Rucaparib 
    https://medlineplus.gov/druginfo/meds/a617002.html
    ... in a class of medications called poly (ADP-ribose) polymerase (PARP) inhibitors. It works by killing cancer ...
  3. MedlinePlus Drug Information: Niraparib 
    https://medlineplus.gov/druginfo/meds/a617007.html
    ... in a class of medications called poly (ADP-ribose) polymerase (PARP) inhibitors. It works by killing cancer ...
  4. MedlinePlus Drug Information: Talazoparib 
    https://medlineplus.gov/druginfo/meds/a618070.html
    ... in a class of medications called poly (ADP-ribose) polymerase (PARP) inhibitors. It works by stopping or ...
  5. MedlinePlus Drug Information: Niraparib and Abiraterone 
    https://medlineplus.gov/druginfo/meds/a623037.html
    ... in a class of medications called poly (ADP-ribose) polymerase (PARP) inhibitors. It works by killing cancer ...
  6. NLM Digital Collections - Poly ADP-ribose polymerase (PARP) inhibitors for ovarian cancer : effectiveness and value : ... 
    Publication: [Boston, Massachusetts] : Institute for Clinical and Economic Review, September 28, 2017
    resource.nlm.nih.gov/101723925
    Poly ADP-ribose polymerase (PARP) inhibitors for ovarian cancer : effectiveness and value : final evidence report ... Poly(ADP-ribose) Polymerase Inhibitors -- therapeutic use
  7. 2019New_Mesh_Tree_Hierarchy.txt 
    https://www.nlm.nih.gov/.../download/2019New_Mesh_Tree_Hierarchy.txt
    ... 759.646.138.124.070.125 Adenosine Diphosphate Ribose D03.633.100.759.646.138.124.070.125.040 O-Acetyl-ADP-Ribose D03.633.100.759.646.138.124.070.125.195 Cyclic ADP-Ribose D03.633.100.759.646.138.180 Adenosine ...
  8. Genetics of Breast and Gynecologic Cancers (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK65767
    ... 166 ] Furthermore, novel agents such as poly (ADP-ribose) polymerase (PARP) inhibitors may be used in the ... and TIRAPR , which codes for a poly (ADP-ribose) polymerase, molecules that may be important in BRCA1/ ...
  9. pdf2018NewHeadingsSingleColumn508.pdf 
    https://www.nlm.nih.gov/.../2018NewHeadingsSingleColumn508.pdf
    ... Post-translational modification of proteins with ADENOSINE DIPHOSPHATE RIBOSE. Tree locations: Protein Processing, Post-Translational G02.111. ... Binding Factor A repressor protein with poly(ADP)-ribose binding activity that binds CHROMATIN and DNA; its ...
  10. pdf2017MeshTreesWithChangesShown.pdf 
    https://www.nlm.nih.gov/.../2017MeshTreesWithChangesShown.pdf
    ... Adenosine Diphosphate Sugars Adenosine Diphosphate Glucose Adenosine Diphosphate Ribose O-Acetyl-ADP-Ribose Cyclic ADP-Ribose Adenosine Monophosphate Adenosine Phosphosulfate Adenosine ...
first · previous · 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · next · last